Sidén
Hans Sidén, Sollentuna SE
Patent application number | Description | Published |
---|---|---|
20140206771 | LIQUID PHARMACEUTICAL COMPOSITION COMPRISING NITISINONE - The invention concerns a liquid pharmaceutical formulation suitable for oral administration, comprising a suspension of an effective amount of micronized 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (nitisinone); and citric acid buffer having a pH in the range of 2.5 to 3.5. The formulation is useful in the treatment of disorders and diseases in which inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) is desirable, e.g. in hereditary tyrosinaemia type I. | 07-24-2014 |
Johan Sidén, Sundsvall SE
Patent application number | Description | Published |
---|---|---|
20100090802 | SENSOR ARRANGEMENT USING RFID UNITS - A sensor arrangement suitable for determining a condition. A first RFID-unit and a second RFID-unit are subjected to the condition. The second RFID-unit is at least partly provided with a degradation unit having such properties that, when subjected to the condition, the second RFID-unit is functionally degraded to a greater extent than the first RFID-unit. A sensor arrangement product includes at least one sensor arrangement. | 04-15-2010 |
Johan Sidén, Sundsvall SE
Patent application number | Description | Published |
---|---|---|
20100090802 | SENSOR ARRANGEMENT USING RFID UNITS - A sensor arrangement suitable for determining a condition. A first RFID-unit and a second RFID-unit are subjected to the condition. The second RFID-unit is at least partly provided with a degradation unit having such properties that, when subjected to the condition, the second RFID-unit is functionally degraded to a greater extent than the first RFID-unit. A sensor arrangement product includes at least one sensor arrangement. | 04-15-2010 |